The 5 most frequently viewed records in the last month are:
1. Cost-utility analysis of imatinib mesilate for the treatment of advanced stage chronic myeloid leukaemia
2. Cost-utility analysis of imatinib mesylate for the treatment of chronic myelogenous leukemia in the chronic phase
3. Efficacy of surgery and imatinib mesylate in the treatment of advanced gastrointestinal stromal tumor: a systematic review
4. Imatinib mesylate for chronic myeloid leukemia: what do we really know?
5. Imatinib (Glivec) for Philadelphia positive acute lymphoblastic leukaemia - horizon scanning review